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TO THE EDITOR
Cutaneous lymphocyte antigen (CLAþ )
T cells constitute a relevant subset of
circulating memory T cells in the
pathological mechanisms of psoriasis
(Gottlieb, 2005; Schon and Boehncke,
2005), and other T-cell-mediated dis-
eases (Santamaria-Babi, 2004). In unin-
volved skin, distant from the plaque
edge, a significant infiltration of CLAþ
T, CD8þ , and memory CD45R0þ T
cells develops. This phenomenon
seems to occur before epidermal hy-
perproliferation takes place (Davison
et al., 2001; Vissers et al., 2004). A
recent study has shown a correlation
between the number of circulating
CLAþCD8þ T cells and the severity
of the disease (Sigmundsdottir et al.,
2001). However, the frequency and
phenotype of this circulating skin-hom-
ing population between acute and
chronic state psoriasis is not known.
Therefore, we were interested in deter-
mining whether there were differences
in the frequency of circulating human
leukocyte antigen (HLA)-DRþ T cells in
either CLAþ or CLA subsets in differ-
ent types of psoriasis.
We studied 31 adult patients with
psoriasis (15 acute psoriasis vulgaris
and 16 chronic psoriasis) and 11
healthy subjects. Patients presenting
with ‘‘acute lesions’’, including those
who had suffered an acute relapse of
psoriasis of less than 6 weeks duration
(15 patients), included seven patients
with guttate psoriasis and eight with
plaque psoriasis. Patients presenting
with ‘‘chronic lesions’’ were those with
chronic and stable psoriatic plaques
persisting for more than 6 weeks (16
patients). The medical ethical commit-
tee of the Hospital del Mar approved all
the studies described and the study was
conducted according to Declaration of
Helsinki principles. Informed consent
was obtained to use blood from patients
and healthy controls. Tables 1 and 2 are
presented as Supplementary material
on the web and show the percentage
of CLAþ /CLA subsets and psoriasis
area and severity index (PASI) and body
surface area (BSA) data by individual
patient. Data were analyzed using the
Mann–Whitney statistic test. Correla-
tions were calculated by the Pearson’s
correlation coefficient.
Figure 1 presents the frequency of
circulating CD3þHLA-DRþ cells, in
either CLAþ or CLA subset, in the
study groups. Patients with guttate or
acute plaque psoriasis had the highest
levels of circulating CLAþCD3þHLA-
DRþ cells (P¼0.002 and P¼0.0005,
respectively) compared to chronic psor-
iasis patients and controls, and such
percentages directly correlated with
PASI and BSA in acute plaque psoriasis
(P¼0.60 and P¼ 0.61, respectively).
Interestingly, no significant correlation
was found with PASI or BSA and the
frequency of circulating CLACD3þ
HLA-DRþ cells in either guttate or
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Figure 1. Frequency of circulating CLAþ and CLACD3þHLA-DRþ subsets in various psoriasis form s
and correlation with PASI and BSA. Peripheral blood mononuclear cells from the study subjects were
stained with HECA-452-FITC (Pharmingen, San Diego, CA), anti-CD3-PerCP and either anti-HLA-DR,
both conjugated to PE (Becton Dickinson, San Jose, CA). The same staining was performed with anti-
CD4-PerCP antibody instead of anti-CD3-PerCP (Becton Dickinson, San Jose, CA). Specific staining was
determined for each marker using appropriate isotype control antibodies (Becton Dickinson, San Jose,
CA). Analysis was performed using a FACScalibur flow cytometer (Becton Dickinson, San Jose, CA).
Values are expressed as mean7SD; *P¼0.002, **P¼ 0.0005, and ***P¼0.005. Correlations of PASI
and BSA with the different subpopulations are presented in the box under figure.
Abbreviations: BSA, body surface area; CLA, cutaneous lymphocyte antigen; HLA, human leukocyte
antigen; PASI, psoriasis area and severity index
acute plaque psoriasis patients. Con-
versely, in chronic psoriasis patients,
both CLAþ and CLA subsets of circu-
lating CD3þHLA-DRþ cells were in-
versely correlated with PASI and BSA.
Regarding the percentage of
CD4þHLA-DRþ cells, as shown in
Figure 2, guttate and acute plaque
psoriasis patients presented signifi-
cantly higher percentage of
CLAþCD4þHLA-DRþ than those with
chronic psoriasis or controls (P¼0.007
and 0.0006), as in the case of CD3þ
cells. However, such percentages
showed a lower correlation with PASI
or BSA than with CLAþCD3þHLA-
DRþ cells. Finally, for CD3þHLA-
DRþ cells in chronic psoriasis patients,
both CLAþ and CLA subsets of circu-
lating CD4þHLA-DRþ cells were in-
versely correlated with PASI and BSA.
Circulating CLAþ T cells may be
involved in the initiation of psoriatic
lesions (Nickoloff and Nestle, 2004);
however, few studies have compared
the phenotype of circulating skin-hom-
ing T cells in acute or chronic psoriatic
patients. Our data indicate that in the
acute stage of psoriasis, the frequency
of circulating CLAþCD3þHLA-DRþ
cells is increased in comparison with
chronic psoriasis and controls, and it
directly correlates with PASI and BSA in
acute plaque psoriasis patients. Con-
versely, in chronic plaque psoriasis
CD3þHLA-DRþ cells, both CLAþ
and CLA were inversely correlated
with PASI and BSA. These results
suggest a preferential involvement of
activated CLAþCD3þ cells in acute
stages of psoriasis, as they express the
surface activation marker HLA-DR
(Bach and Reinsmoen, 1986). A pre-
vious study found a stronger correlation
between PASI and CLAþCD8þ cells
than CLAþCD4þ cells, although those
patients were chronic (Sigmundsdottir
et al., 2001). Our results extend the
phenotypic characterization of CLAþ T
cells to other subsets in acute plaque
psoriasis and guttate psoriasis. We did
not include CD8þ T cells in our study,
as in our study, the frequency of
CLAþCD8þ cells was very low. The
higher correlation of CLAþCD3þHLA-
DRþ cells than CLAþCD4þHLA-DRþ
cells with PASI and BSA may suggest a
possible involvement of CLAþCD8þ
HLA-DRþ cells in the acute stage,
although this hypothesis remains to be
elucidated. Our data support a role for
activated CLAþ T cells in the acute,
rather than in the chronic stage of
psoriasis.
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SUPPLEMENTARY MATERIAL
Table S1. Percentage of CLAþ subsets by patient.
Table S2. Percentage of CLA subsets by patient.
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Figure 2. Frequency of circulating CLAþ and CLACD4þHLA-DRþ subsets in various psoriasis
forms and correlation with PASI and BSA. Values are expressed as mean7SD; ****P¼0.007,
*****P¼ 0.0006, and ******P¼0.0003. Correlations of PASI and BSA with the different subpopulations
are presented in the box under figure.
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